+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Drug Discovery Informatics - Global Market Trajectory & Analytics

  • ID: 4804178
  • Report
  • April 2021
  • Region: Global
  • 175 pages
  • Global Industry Analysts, Inc
Global Drug Discovery Informatics Market to Reach $3.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Drug Discovery Informatics estimated at US$2 Billion in the year 2020, is projected to reach a revised size of US$3.8 Billion by 2027, growing at a CAGR of 9.8% over the analysis period 2020-2027. Sequencing & Target Data Analysis, one of the segments analyzed in the report, is projected to record a 11.5% CAGR and reach US$1.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Docking segment is readjusted to a revised 8.3% CAGR for the next 7-year period.



The U.S. Market is Estimated at $591.8 Million, While China is Forecast to Grow at 9.2% CAGR

The Drug Discovery Informatics market in the U.S. is estimated at US$591.8 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$657.8 Million by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 8% CAGR.

Molecular Modelling Segment to Record 10.2% CAGR

In the global Molecular Modelling segment, USA, Canada, Japan, China and Europe will drive the 10.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$329.5 Million in the year 2020 will reach a projected size of US$657.8 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$441.1 Million by the year 2027.

Select Competitors (Total 41 Featured):
  • Certara USA, Inc.
  • Charles River Laboratories International, Inc.
  • Collaborative Drug Discovery, Inc.
  • Dassault Systemes
  • GVK Biosciences Pvt., Ltd.
  • IBM Corporation
  • Infosys Ltd.
  • Jubilant Life Sciences Ltd.
  • Novo Informatics Pvt., Ltd.
  • Openeye Scientific Software
  • PerkinElmer, Inc.
  • Schrodinger LLC
  • Selvita SA
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • Drug Discovery Informatics: A Prelude
  • Robust Drug Discovery Investments in Response to Growing Global Disease Burden Provides the Foundation for Growth in the Market
  • Growing Global Disease Burden Intensifies the R&D Urgency for New & Potent Drugs: Global Disease Burden (In Million DALYs (Disability-Adjusted Life Years)) for the Years 2015, 2017 & 2019
  • Rising Drug Development Spending Acts as the Chief Catalyst for the Adoption of Drug Discovery Informatics: Global Pharmaceutical R&D Spending (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Migration to Data Driven Drug Development Provides the Cornerstone for Growth in the Market
  • Growing Focus on Optimizing Hit to Lead (H2L) Processes in Early Stage Drug Discovery to Benefit Growth of Drug Discovery Informatics/Chemoinformatics
  • Growing Use of In-Silico Methods in Drug Development Bodes Well for the Use of Informatics
  • The Rise of Nanoinformatics as the New Era of Research in Nanomedicine Marks the Beginning of Use of Informatics in Nanomedicine
  • Exploding Commercial Opportunity for Nanomedicine Bodes Well for the Growth of Nanoinformatics: Global Nanomedicine Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Cloud Computing Emerges to Play a Key Role in Bioinformatics
  • Cost Benefits Over In-House Informatics Helps Expand the Commercial Visibility of Outsourced Informatics
  • Continuously Evolving CRO Industry Highlights the Growing Importance & Value of Pharma R&D Outsourcing: Global Contract Research Organization (CRO) Market (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Robust Adoption of Bioinformatics Services Highlights the Growing Dominance of Informatics Outsourcing Over Traditional In-House Informatics: Global Bioinformatics Services Market (In US$ Billion) by Service Type for the Years 2017, 2019, 2022 and 2024
  • Competitive Challenges Faced by the Pharma Industry & the Ensuing Need for Decision Support Tools & Collaborative Discovery Opens the Flood Gates of Opportunity for Drug Discovery Informatics
  • Rising Global Healthcare Spending Spurs Government Focus On Cost Containment Driving Pharma Companies to Cut Drug Prices by Reducing Research Costs: Global Healthcare Spending (In US$ Trillion) by Government, Private & Consumer Out-of-Pocket for the Years 2017, 2019, 2022 and 2025
  • Productivity Gains, Acceleration of Speed & Success of Drug Discovery Research Drive Adoption of Drug Discovery Informatics
  • Move Towards Value-Based Care & the Resulting Emergence of the Era of Precision Medicine Catalyzes the Commercial Value of Drug Discovery Informatics
  • Robust Outlook for Precision Medicine Strengthens the Business Case for Drug Discovery Informatics: Global Market for Precision Medicine (In US$ Billion) for the Years 2017, 2019, 2022 and 2024
  • Table 1: World Current & Future Analysis for Drug Discovery Informatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for Sequencing & Target Data Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for Sequencing & Target Data Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Docking by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Docking by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Molecular Modelling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Molecular Modelling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Library Preparation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Library Preparation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Other Functions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Other Functions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Contract Research Organizations (CROS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Contract Research Organizations (CROS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 21: World Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 22: World 7-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS

UNITED STATES
  • Dwindling Government Funding Support for Healthcare R&D, A Major Challenge for Growth in the Country
  • Table 23: USA Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 24: USA 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 25: USA Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: USA 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 27: USA Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 28: USA 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
CANADA
  • Table 29: Canada Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 30: Canada 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 31: Canada Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Canada 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 33: Canada Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 34: Canada 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
JAPAN
  • Table 35: Japan Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 36: Japan 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 37: Japan Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: Japan 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 39: Japan Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 40: Japan 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
CHINA
  • Table 41: China Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 42: China 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 43: China Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 44: China 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 45: China Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 46: China 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
EUROPE
  • Table 47: Europe Current & Future Analysis for Drug Discovery Informatics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 48: Europe 7-Year Perspective for Drug Discovery Informatics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 49: Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 51: Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 52: Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 53: Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 54: Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
FRANCE
  • Table 55: France Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: France 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 57: France Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 58: France 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 59: France Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 60: France 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
GERMANY
  • Table 61: Germany Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 63: Germany Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 64: Germany 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 65: Germany Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 66: Germany 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
ITALY
  • Table 67: Italy Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 69: Italy Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 70: Italy 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 71: Italy Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 72: Italy 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
UNITED KINGDOM
  • Table 73: UK Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: UK 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 75: UK Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 76: UK 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 77: UK Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 78: UK 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
REST OF EUROPE
  • Table 79: Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 81: Rest of Europe Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 82: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 83: Rest of Europe Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 84: Rest of Europe 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
ASIA-PACIFIC
  • Table 85: Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 87: Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 88: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 89: Asia-Pacific Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 90: Asia-Pacific 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
REST OF WORLD
  • Table 91: Rest of World Current & Future Analysis for Drug Discovery Informatics by Function - Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of World 7-Year Perspective for Drug Discovery Informatics by Function - Percentage Breakdown of Value Sales for Sequencing & Target Data Analysis, Docking, Molecular Modelling, Library Preparation and Other Functions for the Years 2020 & 2027
  • Table 93: Rest of World Current & Future Analysis for Drug Discovery Informatics by Solution - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 94: Rest of World 7-Year Perspective for Drug Discovery Informatics by Solution - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
  • Table 95: Rest of World Current & Future Analysis for Drug Discovery Informatics by End-Use - Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 96: Rest of World 7-Year Perspective for Drug Discovery Informatics by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, Contract Research Organizations (CROS) and Other End-Uses for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 41
Note: Product cover images may vary from those shown
Adroll
adroll